他唑巴坦钠结构式
|
常用名 | 他唑巴坦钠 | 英文名 | Tazobactam Sodium Salt |
|---|---|---|---|---|
| CAS号 | 89785-84-2 | 分子量 | 322.27300 | |
| 密度 | 1.92 g/cm3 | 沸点 | 707.1ºC at 760 mmHg | |
| 分子式 | C10H11N4NaO5S | 熔点 | 140-147ºC | |
| MSDS | 中文版 美版 | 闪点 | 381.4ºC |
他唑巴坦钠用途Tazobactam sodium 是 β-内酰胺酶抑制剂类抗生素。Ceftolozane 与Tazobactam 联合应用,可提高头孢噻嗪对多种产 ESBL 肠杆菌科和部分类杆菌属的抗菌活性。 |
| 中文名 | 他唑巴坦钠 |
|---|---|
| 英文名 | tazobactam sodium |
| 中文别名 | [2S-(2a,3b,5a)]-3-甲基-7-氧代-3-(1H-1,2,3-三氮唑-1-基甲基)-4-硫代-1-氮杂双环[3,2,0]庚烷-2-羧酸钠 4,4-二氧化物 | 泰唑巴坦钠 |
| 英文别名 | 更多 |
| 密度 | 1.92 g/cm3 |
|---|---|
| 沸点 | 707.1ºC at 760 mmHg |
| 熔点 | 140-147ºC |
| 分子式 | C10H11N4NaO5S |
| 分子量 | 322.27300 |
| 闪点 | 381.4ºC |
| 精确质量 | 322.03500 |
| PSA | 133.67000 |
| 储存条件 | Store at 0-5°C |
| 水溶解性 | H2O: 50 mg/mL, clear, colorless |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危害码 (欧洲) | Xi |
| 风险声明 (欧洲) | 36/37/38 |
| 安全声明 (欧洲) | S22-S24/25 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
| RTECS号 | XI0191500 |
| 海关编码 | 2934999090 |
|
~%
他唑巴坦钠 89785-84-2 |
| 文献：Journal of Medicinal Chemistry, , vol. 30, # 8 p. 1469 - 1474 |
|
~%
他唑巴坦钠 89785-84-2 |
| 文献：EP1759697 A1, ; Page/Page column 2-3 ; |
| 他唑巴坦钠上游产品 3 | |
|---|---|
| 他唑巴坦钠下游产品 0 | |
| 海关编码 | 2934999090 |
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation.
Clin. Chem. Lab Med. 53(5) , 781-91, (2015) Recent studies have demonstrated highly variable blood concentrations of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in critically ill patients with a high incidence of ... |
|
|
DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.
Nucleic Acids Res. 39 , D1035-41., (2011) DrugBank (http://www.drugbank.ca) is a richly annotated database of drug and drug target information. It contains extensive data on the nomenclature, ontology, chemistry, structure, function, action, ... |
|
|
Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum beta-lactamases.
J. Antimicrob. Chemother. 51 , 605-612, (2003) MICs of piperacillin/tazobactam are conventionally determined by varying the concentration of piperacillin in the presence of a fixed 4 mg/L tazobactam. When tested in this way, the MIC distribution f... |
| 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt, (2S,3S,5R)- |
| 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt, (2S,3S,5R)- |
| Sodium (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide |
| (2S,3S,5R)-3-méthyl-7-oxo-3-(1H-1,2,3-triazol-1-ylméthyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate-4,4-dioxyde de sodium |
| Tazobactam Sodium |
| MFCD00917472 |
| Sodium (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, 4,4-dioxide |
| [2S-(2a,3b,5a)]-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide sodium salt |
| 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt, (2S,3S,5R)- (1:1) |
| Tazobactam sodium salt |
| CL 307,579 |
查看所有供应商和价格请点击：
